- 全部删除
您的购物车当前为空
Mopidamol (RA 233) 是一种磷酸二酯酶抑制剂,是 dipyridamole 衍生物,具有抗癌活性,可预防实验性糖尿病的视网膜血管缺陷。


为众多的药物研发团队赋能,
让新药发现更简单!
Mopidamol (RA 233) 是一种磷酸二酯酶抑制剂,是 dipyridamole 衍生物,具有抗癌活性,可预防实验性糖尿病的视网膜血管缺陷。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,750 | In stock | |
| 5 mg | ¥ 6,480 | In stock | |
| 10 mg | ¥ 8,820 | In stock | |
| 25 mg | ¥ 12,800 | In stock | |
| 50 mg | ¥ 15,300 | In stock | |
| 100 mg | ¥ 19,500 | In stock |
Mopidamol 相关产品
| 产品描述 | Mopidamol (RA 233) is a phosphodiesterase inhibitor, a dipyridamole derivative, with anticancer activity that prevents retinal vascular defects in experimental diabetes. |
| 靶点活性 | Lipid peroxidation:89 μmol/L |
| 别名 | 莫哌达醇, Rapenton, RA-233, RA233, RA 233, OLX 102 |
| 分子量 | 421.49 |
| 分子式 | C19H31N7O4 |
| CAS No. | 13665-88-8 |
| Smiles | N(CCO)(CCO)C1=NC=2C(=NC(N(CCO)CCO)=NC2C=N1)N3CCCCC3 |
| 密度 | 1.31g/cm3 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 50 mg/mL (118.63 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容